Volkswagen approaches potential companies to sell MAN Energy Solutions
By Nikita Chaurasia  Date: 2019-05-07

Volkswagen approaches potential companies to sell MAN Energy Solutions

VW anticipated MAN Energy Solutions to reach a valuation of around €3 billion ($3.36 billion) in a potential sale

German automotive manufacturing giant Volkswagen has reportedly approached several companies who can be potential buyers of MAN Energy Solutions, which makes large diesel engines for power generators and ships.

Sources familiar with the matter informed that Herbert Diess, Volkswagen Chief Executive, is working to simplify and slim down the group, which comprises of 12 brands, buses, cars, trucks, electric bicycles, and motorbikes as part of its global business.

Apparently, Volkswagen has not yet commenced a formal sales process or selected an adviser for the sale of the company, however, it has contacted competitors in the engine manufacturing business such as private-equity owned Jenbacher, Wartsila and Cummins.

Sources further stated that the company anticipates MAN Energy Solutions to reach a valuation of around 3 billion euros ($3.36 billion) in a potential sale.

Seemingly, the business previously known as MAN Diesel & Turbo, also produces turbochargers used in the oil and gas industry and in 2018, it had reported operating revenues of 133 million euros on sales of 3.1 billion euros.

It could attract interest from Alfa Laval, Mitsubishi Heavy and also from private equity groups including Cinven, Bain, and EQT if it is put up for sale formally, sources mentioned.

The potential sales process comes after earlier in the year Volkswagen decided to cancel plans for an IPO of its Traton trucks division, which consists of Scania, Volkswagen Caminhoes e Onibus and MAN brands.

For the uninitiated, MAN Energy Solutions was a part of VW’s trucks brand MAN initially, but last year some of the assets of MAN were transferred to Volkswagen as part of efforts to modernize Traton ahead of the planned listing.

Volkswagen Group is a German-based multinational auto maker headquartered in Wolfsburg, Lower Saxony. The company is into manufacturing, designing, and distributing commercial and passenger vehicles, turbomachinery, engines, and motorcycles and provides related services including leasing, financing, and fleet management.

Source credit: https://in.reuters.com/article/volkswagen-unit-divestiture/volkswagen-sounds-out-buyers-for-man-energy-solutions-sources-idINKCN1SC1CM

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...